Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd.

MJID
Ping An Biomedical Co., Ltd.US flagNASDAQ Global Market
1.24
USD
- -
- -
25.42MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
Revenue per Share
7.24
5.59
4.03
- -
Basic EPS, GAAP
0.38
0.35
-0.05
- -
Free Cash Flow per Basic Share
-2.28
1.03
-0.3
- -
Dividend per Share
- -
0.24
0.47
- -
Book Value per Share
-0.15
0.22
-0.32
- -
Tangible Book Value per Share
-0.15
0.22
-0.29
- -
Basic Weighted Avg Shares
14
20
20
- -
Sales/Revenue/Turnover
100
115
83
88
Operating Margin (%)
9.06
9.73
1.67
- -
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
5
7
-1
-1
Effective Tax Rate (%)
33.32
24.92
2,484.34
- -
Profit Margin (%)
5.24
6.31
-1.2
-1.47
Working Capital
-5
2
-9
-10
LT Debt
- -
- -
- -
- -
Total Equity
-2
5
-6
-7
Return on Invested Capital (%)
- -
34.67
-112.53
- -
Return on Capital (%)
- -
25.12
-111.22
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
22.67%
Free Cash Flow
- -
- -
-340.52%
Net Income, GAAP
- -
- -
29.2%
Sales/Revenue/Turnover
- -
- -
6.13%
Total Cash Common Dividend
- -
- -
-96.64%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
115
2023
- -
- -
- -
- -
83
2024
- -
- -
- -
- -
88

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
0.35
2023
- -
- -
- -
- -
-0.05
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
0.24
2023
- -
- -
- -
- -
0.47
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Lina Jiang
Full Time Employees
8
Sector
Consumer Cyclical
Industry
Manufacturing - Textiles
Address
China United Plaza Cheung Sha Wan Hong Kong 999077
IPO Date
Jul 18, 2025
Business
Ping An Biomedical Co., Ltd., operating under the ticker MJID, recently underwent a significant transformation, with shareholders approving its name change from Majestic Ideal Holdings Limited in September 2025 to reflect a new strategic emphasis on biomedical and healthcare technologies. The company, which successfully completed its initial public offering and began trading on Nasdaq in July 2025, previously focused on providing comprehensive supply chain management services within the apparel sector. Through its subsidiary, New Brand Cashmere Products Co., Ltd., its integrated offerings spanned market trend analysis, product design and development, sourcing of raw materials, particularly cashmere, production and quality oversight, and efficient logistics coordination. The company supplied a variety of yarn products, textile materials, and finished garments, while also engaging in real property investment and warehousing solutions. Its clientele historically included brand owners, textile manufacturers, apparel sourcing agents, and digital fashion and garment retailers. Established in 2021, Ping An Biomedical Co., Ltd. is based in Cheung Sha Wan, Hong Kong.

Company News

APIChat
  • Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter

  • Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting

  • Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering

  • U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings

  • Majestic Ideal Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq